PDTM-42. TARGETED INHIBITION OF BET BROMODOMAIN AND JMJD3 PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA | Zendy

Hiroaki Katagi | Zendy; Ali Zhang | Zendy; Gavin T. Blyth | Zendy; Frank Eckerdt | Zendy; Patrick A. Ozark | Zendy; Lihua Zou | Zendy; Xingyao He | Zendy; Kathryn E. Loughlin | Zendy; Takahiro Sasaki | Zendy; Craig Horbinski | Zendy; Rishi Lulla | Zendy; Amanda Saratsis | Zendy; Stewart Goldman | Zendy; C. David James | Zendy; Ali Shilatifard | Zendy; Rintaro Hashizume | Zendy

Open Access

PDTM-42. TARGETED INHIBITION OF BET BROMODOMAIN AND JMJD3 PROTEINS FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA

Author(s) -

Hiroaki Katagi,

Ali Zhang,

Gavin T. Blyth,

Frank Eckerdt,

Patrick A. Ozark,

Lihua Zou,

Xingyao He,

Kathryn E. Loughlin,

Takahiro Sasaki,

Craig Horbinski,

Rishi Lulla,

Amanda Saratsis,

Stewart Goldman,

C. David James,

Ali Shilatifard,

Rintaro Hashizume

Publication year - 2018

Publication title -

neuro-oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.005

H-Index - 125

eISSN - 1523-5866

pISSN - 1522-8517

DOI - 10.1093/neuonc/noy148.881

Subject(s) - bromodomain , bet inhibitor , epigenetics , histone , cancer research , methylation , histone h3 , brd4 , glioma , acetylation , demethylase , in vivo , histone methylation , biology , dna methylation , chemistry , microbiology and biotechnology , biochemistry , gene expression , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research